KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
KLRS
84 hedge funds and large institutions have $502M invested in Kalaris Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 26 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
+9
Holders Change %
+12%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
26
Reduced
25
Closed
11
Calls
$1K
Puts
$1K
Net Calls
–
Net Calls Change
-$5.2M
Top Buyers
| 1 |
1
Lido Advisors
Los Angeles,
California
|
$8.28M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$15.9M |
| 3 |
WP
3
Woodline Partners
San Francisco,
California
|
$28.1M |
| 4 |
4
AllianceBernstein
Nashville,
Tennessee
|
$26.3M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$46.4M |
Top Sellers
| 1 |
1
BlackRock
New York
|
$34.5M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$127M |
| 3 |
RG
3
Redmile Group
San Francisco,
California
|
$31.3M |
| 4 |
4
Goldman Sachs
New York
|
$1.56M |
| 5 |
5
Marshall Wace
London,
United Kingdom
|
$0 |
